Monocyte chemoattractant protein-1 (MCP-1) is a major signal for the accumulation of monocytes/macrophages in several diseases [3] . Aukrust et al.
reported that circulating levels of MCP-1 were increased in patients with congestive heart failure and that the levels were inversely correlated with left ventricular ejection fraction (LVEF) [3] . However, the expression of MCP-1 in failing hearts remains uncertain. Therefore, we examined whether MCP-1 was expressed in the myocardium of DCM patients and whether the expression level was correlated with the degree of impairment of cardiac function.
Methods

Subjects
The patient population studied comprised 20 consecutive patients (13 men and 7 women; mean age 54 ± 11 years) admitted to Okayama (Japan) University Hospital between 1998 and 2000.
MCP-1 assay
Serum levels of MCP-1 were measured using a human MCP-1 ELISA system -4 - 
Results
The serum levels of MCP-1 in 20 patients with DCM were significantly elevated compared with those in healthy 33 control subjects (226 ± 54 versus 176 ± 32 pg/mL, p<0.0001). Expression of MCP-1 was found in all myocardial biopsy samples from DCM patients but not in those from control subjects. Positive immunohistochemical staining for MCP-1 was distinct in cardiac myocytes (Fig. 1B) , interstitium and infiltrating cells (Fig. 1C) . Semi-quantitative analysis revealed that the expression of MCP-1 in the myocardium was inversely correlated with LVEF (r =-0.669, p<0.05) (Fig. 2) . To determine the chemotactic effect of MCP-1 in the myocardium, we calculated the numbers of macrophages that were positively stained with anti-human CD68 antibody in the endomyocardial biopsy samples. The mean number of macrophages in the myocardial biopsy samples from DCM patients was 12-fold higher than that in samples from control subjects (1.2 ± 2.1 versus 0.1 ± 0.3/mm 2 , p<0.05).
Discussion
The major new finding of this work is that MCP-1 was expressed in the myocardium of DCM patients and that the expression level was inversely correlated with LVEF.
Seino et al. reported the detection of MCP-1 mRNA expression in human endomyocardial biopsy specimens from DCM patients by polymerase chain reaction analysis [4] . The present study is the first to demonstrate expression of MCP-1 protein in the cardiac interstitium and myocytes of DCM patients. Furthermore, the number of infiltrating macrophages was increased in the myocardium of DCM patients.
MCP-1 may be an important factor in the pathogenesis of DCM. 
